Cargando…
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
Hepatocellular carcinoma (HCC) is a common malignant tumor. LukS-PV is the S component of Panton-Valetine leukocidin (PVL), which is secreted by Staphylococcus aureus. This study investigated the effects of LukS-PV on the proliferation, apoptosis, and cell-cycle progression of HCC cells and the mech...
Autores principales: | Wang, Ziran, Yu, Wenwei, Qiang, Yawen, Xu, Liangfei, Ma, Fan, Ding, Pengsheng, Shi, Lan, Chang, Wenjiao, Mei, Yide, Ma, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321822/ https://www.ncbi.nlm.nih.gov/pubmed/32637573 http://dx.doi.org/10.1016/j.omto.2020.05.006 |
Ejemplares similares
-
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression
por: Wang, Ziran, et al.
Publicado: (2020) -
LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression
por: Xu, Xuexue, et al.
Publicado: (2022) -
LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis
por: Ma, Fan, et al.
Publicado: (2020) -
Engineering of the LukS-PV and LukF-PV subunits of Staphylococcus aureus Panton-Valentine leukocidin for Diagnostic and Therapeutic Applications
por: Okolie, Charles Emeka, et al.
Publicado: (2013) -
Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model
por: Karauzum, Hatice, et al.
Publicado: (2013)